IYH:ARCA-iShares U.S. Healthcare (USD)

ETF | Health | NYSE Arca

Last Closing

USD 66.38

Change

0.00 (0.00)%

Market Cap

USD 1.71B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to track the investment results of Dow Jones U.S. Health Care Index composed of U.S. equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.

Inception Date: 12/06/2000

Primary Benchmark: DJ US Health Care TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.44%

Management Expense Ratio: 0.43 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

+0.32 (+0.21%)

USD 42.19B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

+0.19 (+0.26%)

USD 3.02B
FXH First Trust Health Care AlphaD.. 0.63 %

+0.86 (+0.77%)

USD 1.26B
XHE SPDR® S&P Health Care Equipme.. 0.35 %

+1.16 (+1.31%)

USD 0.22B
IDNA iShares Genomics Immunology an.. 0.00 %

+0.65 (+2.67%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF 0.50 %

+1.20 (+3.25%)

USD 0.11B
XHS SPDR® S&P Health Care Service.. 0.35 %

+1.71 (+1.78%)

USD 0.08B
HTEC Robo Global® Healthcare Techn.. 0.00 %

+0.32 (+1.10%)

USD 0.06B
BBP Virtus LifeSci Biotech Product.. 0.79 %

+1.33 (+2.12%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica.. 0.79 %

+0.96 (+3.42%)

USD 0.01B

ETFs Containing IYH

RXD ProShares UltraShort Heal.. 10.32 % 0.77 %

-0.04 (-0.43%)

N/A
RXD ProShares UltraShort Heal.. 10.32 % 0.95 %

-0.04 (-0.43%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -76.81% 14% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -76.81% 14% F 4% F
Trailing 12 Months  
Capital Gain -76.46% 10% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -76.46% 10% F 3% F
Trailing 5 Years  
Capital Gain -65.20% 14% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.20% 14% F 8% B-
Average Annual (5 Year Horizon)  
Capital Gain 9.25% N/A N/A 67% D+
Dividend Return 10.25% N/A N/A 64% D
Total Return 1.00% N/A N/A 22% F
Risk Return Profile  
Volatility (Standard Deviation) 12.22% N/A N/A 72% C
Risk Adjusted Return 83.88% N/A N/A 93% A
Market Capitalization 1.71B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike